Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases.
As part of the Manufacturing Technical Team (within TO CM&S), the Manager, Manufacturing Technical – Drug Product is accountable for the development, implementation, and oversight of the supply at Apellis' Contract Manufacturing Organizations. Will assume the responsibility for deviation handling as a part of the Supplier Relationship Team (SRT) for Drug Product (DP). The individual will be responsible for assuring Drug Product conforms to regulatory and company standards and satisfies GMP regulations. The Manager, Manufacturing Technical – Drug Product will bring advanced skills in late-stage development and commercial phase technical processes, also supporting other functional areas.
Key Responsibilities
Education & Experience
Knowledge, Skills, and Abilities
Travel Requirements: Up to 20% travel expected.
Bachelor's Degree
Base salary for this role will consider multiple factors, including but not limited to, candidate qualifications, relevant expertise, specialized skills, and industry experience in complement-targeted therapies. The targeted base salary range for this position is $114,000-$171,000. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions.
Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more!
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.
For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.